Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Hanall Biopharma (009420)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
35,250 -400    -1.12%
07:48:48 - Closed. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7009420001 
  • Volume: 215,174
  • Bid/Ask: 35,250 / 35,300
  • Day's Range: 35,250 - 36,400
Hanall Biopharma 35,250 -400 -1.12%

009420 Balance Sheet

 
Featured here, the Balance Sheet for Hanall Biopharma, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 113577.19 110792.16 118136.15 106645.39
Cash and Short Term Investments 56497.11 61409.39 53873.36 59567.89
Cash - - - -
Cash & Equivalents 33722.51 33802.88 16368.7 22225.92
Short Term Investments - - 10000 10000
Total Receivables, Net 22524.26 20114.79 36947.48 18544.75
Accounts Receivables - Trade, Net 15630.33 15393.26 29525.41 13461.49
Total Inventory 32384.16 26740.98 25168.79 26457.66
Prepaid Expenses 93.4 162.53 126.14 216.22
Other Current Assets, Total 2078.26 2364.46 2020.39 1858.87
Total Assets 239746.99 241314.25 227224.38 209132.52
Property/Plant/Equipment, Total - Net 19433.94 19237.11 18832.04 18996.22
Property/Plant/Equipment, Total - Gross 50830.11 19237.11 18832.04 49660.09
Accumulated Depreciation, Total -31396.17 - - -30663.87
Goodwill, Net - - - -
Intangibles, Net 1826.39 29352.3 28376.48 1984.29
Long Term Investments 59626.36 69904.84 43055.8 38048.62
Note Receivable - Long Term 6893.93 4721.53 7422.06 5083.26
Other Long Term Assets, Total 7512.01 9953.48 11149.62 11105.85
Other Assets, Total 72483.87 38671.53 35420.64 79465.9
Total Current Liabilities 37651.87 28965.52 32695.51 28649.92
Accounts Payable 11272.58 4915.88 4695.07 6768.53
Payable/Accrued - - - -
Accrued Expenses 3038.67 2058.32 2032.04 1990.19
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 700.22 537.13 588.28 610.68
Other Current liabilities, Total 22640.4 21454.2 25380.12 19280.52
Total Liabilities 53528.62 43630.32 49927.7 43323.11
Total Long Term Debt 590.31 576.75 674.77 676.4
Long Term Debt - - - -
Capital Lease Obligations 590.31 576.75 674.77 676.4
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 15286.44 14088.04 16557.41 13996.79
Total Equity 186218.37 197683.94 177296.68 165809.4
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 26120.32 26120.32 26120.32 26120.32
Additional Paid-In Capital 115039.76 114217.5 114341.11 114184.91
Retained Earnings (Accumulated Deficit) 31362.06 35780.41 35446.2 28155.13
Treasury Stock - Common -13205.35 -13205.35 -13205.35 -13228.16
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 26901.59 34771.06 14594.41 10577.21
Total Liabilities & Shareholders' Equity 239746.99 241314.25 227224.38 209132.52
Total Common Shares Outstanding 50.69 50.69 50.69 50.69
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

009420 Comments

Write your thoughts about Hanall Biopharma
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email